Does BREXUCABTAGENE AUTOLEUCEL Cause Hypernatraemia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypernatraemia have been filed in association with BREXUCABTAGENE AUTOLEUCEL (TECARTUS). This represents 0.3% of all adverse event reports for BREXUCABTAGENE AUTOLEUCEL.
6
Reports of Hypernatraemia with BREXUCABTAGENE AUTOLEUCEL
0.3%
of all BREXUCABTAGENE AUTOLEUCEL reports
3
Deaths
6
Hospitalizations
How Dangerous Is Hypernatraemia From BREXUCABTAGENE AUTOLEUCEL?
Of the 6 reports, 3 (50.0%) resulted in death, 6 (100.0%) required hospitalization.
Is Hypernatraemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXUCABTAGENE AUTOLEUCEL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BREXUCABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (827)
Immune effector cell-associated neurotoxicity syndrome (529)
Neurotoxicity (192)
Death (153)
Pyrexia (119)
Hypotension (109)
Disease progression (93)
Fatigue (86)
Febrile neutropenia (69)
Confusional state (63)
What Other Drugs Cause Hypernatraemia?
TOLVAPTAN (235)
FUROSEMIDE (192)
LITHIUM (186)
SODIUM (136)
LAMOTRIGINE (90)
VALPROIC ACID (88)
OLANZAPINE (87)
METFORMIN (79)
QUETIAPINE (77)
ARIPIPRAZOLE (69)
Which BREXUCABTAGENE AUTOLEUCEL Alternatives Have Lower Hypernatraemia Risk?
BREXUCABTAGENE AUTOLEUCEL vs BRIGATINIB
BREXUCABTAGENE AUTOLEUCEL vs BRILINTA
BREXUCABTAGENE AUTOLEUCEL vs BRILIQUE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE\BRINZOLAMIDE